Skip to main content
SpringerLink
Log in

Ceftriaxone associated with encephalopathy, risk factors identified

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Analysis of the frequency of ceftriaxone-induced encephalopathy using the Japanese Adverse Drug Event Report database International Journal of Clinical Pharmacy : 2 May 2022. Available from: URL: https://doi.org/10.1007/s11096-022-01406-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ceftriaxone associated with encephalopathy, risk factors identified. Reactions Weekly 1905, 6 (2022). https://doi.org/10.1007/s40278-022-14396-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-14396-z

Search

Navigation